公开(公告)号：PT2314321E

公开(公告)日：2014-09-26

申请号：PT10013180

申请日：2000-01-27

Applicant: CODA THERAPEUTICS INC

Inventor： BECKER DAVID LAURENCE ,  GREEN COLIN RICHARD

IPC: A61K48/00 ,  C12N15/09 ,  A61K9/06 ,  A61K9/10 ,  A61K31/70 ,  A61K31/711 ,  A61K38/00 ,  A61K47/16 ,  A61K47/34 ,  A61K47/46 ,  A61P17/02 ,  A61P17/12 ,  A61P17/16 ,  A61P25/00 ,  A61P29/00 ,  A61P43/00 ,  C12N15/11 ,  C12N15/113

公开(公告)号：CA2907349A1

公开(公告)日：2014-09-18

申请号：CA2907349

申请日：2014-03-15

Applicant: CODA THERAPEUTICS INC

Inventor： PHILLIPS ANTHONY ,  EISENBUD DAVID ,  BANNAN SCOTT ,  POOL DAVID ,  MATSUOKA GROVE ,  SUNDERLAND TRACEY ,  DUFT BRADFORD

IPC: H04S5/00 ,  C12N5/00 ,  C12N5/02

Abstract: This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase.

公开(公告)号：DK2314321T3

公开(公告)日：2014-09-08

申请号：DK10013180

申请日：2000-01-27

Applicant: CODA THERAPEUTICS INC

Inventor： BECKER DAVID LAURENCE ,  GREEN COLIN RICHARD

IPC: A61K48/00 ,  C12N15/09 ,  A61K9/06 ,  A61K9/10 ,  A61K31/70 ,  A61K31/711 ,  A61K38/00 ,  A61K47/16 ,  A61K47/34 ,  A61K47/46 ,  A61P17/02 ,  A61P17/12 ,  A61P17/16 ,  A61P25/00 ,  A61P29/00 ,  A61P43/00 ,  C12N15/11 ,  C12N15/113

公开(公告)号：ES2377749T3

公开(公告)日：2012-03-30

申请号：ES05016736

申请日：2000-01-27

Applicant: BECKER DAVID DR ,  GREEN COLIN R DR ,  CODA THERAPEUTICS INC

Inventor： BECKER, DAVID, DR. ,  GREEN, COLIN R., DR.

IPC: A61K48/00 ,  C12N15/09 ,  A61K9/06 ,  A61K9/10 ,  A61K31/70 ,  A61K31/711 ,  A61K38/00 ,  A61K47/16 ,  A61K47/34 ,  A61K47/46 ,  A61P17/02 ,  A61P17/12 ,  A61P17/16 ,  A61P25/00 ,  A61P29/00 ,  A61P43/00 ,  C12N15/11 ,  C12N15/113

Abstract: Una formulación para uso en el tratamiento del cuerpo humano o animal mediante una terapia, cuya formulación comprende: un polinucleótido complementario de una conexina humana; junto con un soporte o un vehiculo farmaceuticamente aceptable.

公开(公告)号：DK1621212T3

公开(公告)日：2012-03-05

申请号：DK05016736

申请日：2000-01-27

Applicant: CODA THERAPEUTICS INC

Inventor： BECKER DAVID DR ,  GREEN COLIN R DR

IPC: A61K48/00 ,  C12N15/09 ,  A61K9/06 ,  A61K9/10 ,  A61K31/70 ,  A61K31/711 ,  A61K38/00 ,  A61K47/16 ,  A61K47/34 ,  A61K47/46 ,  A61P17/02 ,  A61P17/12 ,  A61P17/16 ,  A61P25/00 ,  A61P29/00 ,  A61P43/00 ,  C12N15/11 ,  C12N15/113

公开(公告)号：ZA201005222B

公开(公告)日：2011-07-27

申请号：ZA201005222

申请日：2010-07-21

Applicant: CODA THERAPEUTICS INC

Inventor： DUFT BRADFORD J

IPC: C12N15/113

Abstract: Compositions, articles, devices and methods for the treatment of fibrosis and fibrotic diseases, disorders, and conditions in humans and non-human animals.

公开(公告)号：ZA201004999B

公开(公告)日：2011-07-27

申请号：ZA201004999

申请日：2010-07-14

Applicant: CODA THERAPEUTICS INC

Inventor： BECKER DAVID L ,  DUFT BRADFORD J ,  GREEN COLIN R

Abstract: Methods, compounds, compositions, kits and articles of manufacture comprising one or more gap junction modulating agents for treatment of wounds that do not heal at expected rates, including chronic wounds, delayed healing wounds, incompletely healing wounds, and dehiscent wounds in a subject in need thereof.

公开(公告)号：ZA201005221B

公开(公告)日：2011-06-29

申请号：ZA201005221

申请日：2010-07-21

Applicant: CODA THERAPEUTICS INC

Inventor： DUFT BRADFORD J

IPC: C12N15/113

Abstract: Methods and compositions comprising combinations and uses of a first anti-connexin agent and a second anti-connexin agent, for example, one or more anti-connexin polynucleotides and one or more anti-connexin peptides or peptidomimetics, are provided for the treatmen or prevention of abnormal or excessive scarring.

公开(公告)号：CA2727015A1

公开(公告)日：2009-12-10

申请号：CA2727015

申请日：2009-06-04

Applicant: CODA THERAPEUTICS INC

Inventor： DUFT BRADFORD J ,  GREEN COLIN

IPC: A61P25/00 ,  C12N15/113

Abstract: The present invention relates to delivery, including transdermal delivery, of a therapeutically effective amount of a compound useful for modulating gap junction formation and function, including an oligonucleotide for reducing gap junction formation and function, and methods and compositions for treating a subject suffering from pain associated with a disease, disorder or condition and associated with pain, including but not limited to muscle pain, ligament pain, tendon pain, joint pain and post-operative pain.

公开(公告)号：AU2009255619A1

公开(公告)日：2009-12-10

申请号：AU2009255619

申请日：2009-06-04

Applicant: CODA THERAPEUTICS INC

Inventor： GREEN COLIN ,  DUFT BRADFORD J

IPC: A61P25/00 ,  C12N15/113

Abstract: The present invention relates to delivery, including transdermal delivery, of a therapeutically effective amount of a compound useful for modulating gap junction formation and function, including an oligonucleotide for reducing gap junction formation and function, and methods and compositions for treating a subject suffering from pain associated with a disease, disorder or condition and associated with pain, including but not limited to muscle pain, ligament pain, tendon pain, joint pain and post-operative pain.